http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Kim, Kyuseok,Ha, Injin,Kim, Eunok,Kim, Kyunglee Williams & Wilkins Co 2017 Medicine Vol.96 No.45
<P><B>Abstract</B></P><P>Acne is a multifactorial dermatosis, which is influenced not only by hormones but also by the biochemical relationship between them and the pilosebaceous unit. Inflammatory cytokines, chemokines, active oxygen, and zinc are known to be associated with the development of acne. Further, steroid metabolism is known as one of the important factors related to sebum secretion and comedone formation in acne. However, there is a lack of studies comparing these human biomarkers between healthy individuals and patients with acne. In particular, no study has investigated the relationship between human biomarkers and patterns of acne yet.</P><P>The purpose of this study is to investigate diagnostic human biomarkers in acne by comparing the biological and metabolic biomarkers between healthy individuals and patients with acne and identify the relationship between human biomarkers and patterns of acne.</P><P>This study is a protocol for a cross-sectional study. Forty healthy participants and 60 patients with acne will be recruited at 1 center. We will collect their blood samples and analyze the molecular biological and metabolic biomarkers (cytokines, chemokines, reactive oxygen species, corticotropin-releasing hormone, zinc, amino acid, 1-carbon metabolite, lipid metabolite, etc.). Further, we will administer questionnaires regarding their diet, sleep, stress, and other factors relating to acne and measure their skin elasticity.</P><P>The study protocol was approved by the Institutional Review Board of Oriental Medical Hospital at Kyung Hee Medical Center (KOMCIRB-161118-HR-062). Written informed consent will be obtained from all the participants. The trial was registered in the Clinical Research Information Service, Republic of Korea: KCT0002212.</P><P>This trial will provide evidence regarding diagnostic human biomarkers in acne and the relationship between the human biomarkers and patterns of acne.</P>
In Silico Evaluation of Glucose Control Protocols for Critically Ill Patients
Lee, Jung Chan,Kim, Myeungseon,Choi, Ka Ram,Oh, Tae Jung,Kim, Min Young,Cho, Young Min,Kim, Kyuseok,Kim, Hee Chan,Kim, Sungwan IEEE 2012 IEEE Transactions on Biomedical Engineering Vol.59 No.1
<P>This letter presents an in silico evaluation method of glucose control protocols for critically ill patients with hyperglycemia. Although various glucose control protocols were introduced and investigated in clinical trials, development and validation of a novel glucose control protocol for critically ill patients require too much time and resources in clinical evaluation. We employed a virtual patient model of the critically ill patient with hyperglycemia and evaluated the clinically investigated glucose control protocols in a computational environment. The three-day simulation results presented the time profiles of glucose and insulin concentrations, the amount of enteral feed and intravenous bolus of glucose, and the intravenous insulin infusion rate. The hyperglycemia and hypoglycemia index, blood glucose concentrations, insulin doses, intravenous glucose infusion rates, and glucose feed rates were compared between different protocols. It is shown that a similar hypoglycemia incidence exists in simulation and clinical results. We concluded that this in silico simulation method using a virtual patient model could be useful for predicting hypoglycemic incidence of novel glucose control protocols for critically ill patients, prior to clinical trials.</P>
Joo, Seung-Moon,Lee, Kyoung Ho,Kim, Young Hoon,Kim, So Yeon,Kim, Kyuseok,Kim, Kil Joong,Kim, Bohyoung Radiological Society of North America 2009 Radiology Vol.251 No.3
<P>PURPOSE: To determine the frequency of normal appendix visualization at low-dose (LD) unenhanced computed tomography (CT) performed with a 16- or 64-detector row scanner when images are reviewed by using the sliding slab averaging technique. MATERIALS AND METHODS: The institutional review board approved the study and waived the informed consent requirement. A total of 259 patients, 37 (14.3%) of whom had previously undergone appendectomy, underwent LD unenhanced CT (mean effective dose, 1.7 mSv) performed with a 16- or 64-detector row scanner to assess urinary colic. Three readers used the sliding slab averaging technique to retrospectively review the thin-section (0.67- or 2.00-mm section thickness) images and grade the appendix as absent, unsurely or partly visualized, or clearly and entirely visualized. Interobserver agreement was measured with weighted kappa statistics. McNemar tests were used to compare sensitivity between the readers. Logistic regression analysis was performed to assess the effects of body mass index, patient sex, and type of CT scanner on appendiceal visualization. RESULTS: The kappa statistics for each reader pair were as follows: 0.97 for agreement between readers 1 and 2, 0.93 for agreement between readers 2 and 3, and 0.92 for agreement between readers 1 and 3. Each reader clearly identified the entire appendix in 213 (96.0%), 209 (94.1%), and 205 (92.3%) of the 222 patients without a history of appendectomy. When unsurely or partly visualized appendices were included, the frequencies increased to 99.1% (n = 220), 98.7% (n = 219), and 97.3% (n = 216), respectively, for readers 1, 2, and 3. These frequencies rarely differed between the readers. (P values ranged from .021 to greater than .99.) The three readers consistently reported that the appendix was not visualized in the 37 patients who had undergone appendectomy. None of the tested variables significantly affected appendix visualization. CONCLUSION: Most normal appendices are visualized on thin-section LD unenhanced CT images reviewed with the sliding slab averaging technique.</P>
Kim, Jin-Sun,Choi, Kyuseok,Kim, Ju-Jin,Noh, Dong-Youn,Park, Sang-Kyu,Lee, Ha-Jin,Lee, Haeseong American Scientific Publishers 2007 Journal of Nanoscience and Nanotechnology Vol.7 No.11
<P>We observed that single-walled carbon nanotube (SWNT) was aligned in the presence of TTF. This alignment was induced by a specific interaction between SWNT and tetrathiafulvalene (TTF), a well-known organic donor. The interaction between the two molecules can be explained by a charge-transfer, which was confirmed by X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. The binding energies of S (2P1/2) and S (2P3/2) were shifted from 163.0 eV and 164.1 eV to 163.9 eV and 165.1 eV, respectively. In Raman spectra of the SWNT-TTF, three peaks of SWNT in radial breathing mode were also upshifted by 4-5 cm<SUP>−1</SUP>. The charge-transfer interaction also contributed in modifying the electronic structure of SWNT and furthermore enhanced the electrical conductivity of SWNT. A more conductive thin film was fabricated using the SWNT-TTF. Four-probe measurement revealed that the surface resistance of the SWNT-TTF film was reduced to 4.359 Ω at room temperature while that of SWNT film was 6.894 Ω. These results enable carbon nanotubes to be utilized more for practically for industrial applications in fabricating peculiar nano-sized building blocks.</P>
Kim, Yu-Kang,Yeom, Mijung,Kang, SeHyun,Park, Hi-Joon,Kim, Kyuseok,Lee, Hyangsook Hindawi 2017 Evidence-based Complementary and Alternative Medic Vol.2017 No.-
<P>This study aims to test the feasibility of a randomised clinical trial to evaluate how acupuncture affects atopic dermatitis (AD) symptoms and quality of life and to explore potential biomarkers that may be associated with AD. It is a sham-controlled trial in which 30 eligible patients will be randomly allocated in a 1 : 1 : 1 ratio to one of three groups: verum acupuncture (VA) group 1 (3 times weekly for 4 weeks); VA group 2 (twice weekly for 4 weeks); or sham acupuncture group (SA; twice weekly for 4 weeks). SA will consist of nonpenetrating acupuncture. Outcome measures will include the Visual Analogue Scale for itch, SCORing Atopic Dermatitis, and Eczema Area and Severity Index to evaluate AD symptoms improvement along with the Patient Oriented Eczema Measure and Dermatology Life Quality Index to assess quality of life. Measures will be collected at baseline, once weekly during the treatment period, and after a 4-week follow-up period. Blood collection will be at baseline and 4 and 8 weeks after treatment and compared with healthy controls. Illumina sequencing will be used to profile microRNA expression in each group to explore candidate microRNA biomarkers for specific effects of acupuncture in patients with AD. This trial is registered via US National Institutes of Health Clinical Trials registry (ClinicalTrials.gov) on 15 July 2016, identifier: NCT02844452.</P>